Hématologie, the journal of the French Haematology Society (SFH), provides an invaluable link between all the biomedical disciplines involved in haematology. It has established its position as a major French-language journal aimed at both clinicians and researchers.
Haematology is a rapidly developing area and our journal keeps pace with the changes. With this new format, the Editorial Board wanted to offer readers an even greater focus on clinical matters, a larger board and new sections including "Residents' Corner" and "How do I treat…"
Hématologie presents articles written by top oncology and haematology authors. As well as the six current issues, readers have access to reports from all the big national and international congresses.
Some articles of the journal are published in English, you will find them in the English e-section.
Volume 28, issue 1, Janvier-Février 2022
SFH 2022See full Table of contents >
Here you will find all John Libbey Eurotext (JLE) policies regarding publication in our journals. JLE journals follow the recommendations of the ICMJE (International Committee of Medical Journal Editors). These guidelines are the reference for best practices and ethical standards for the conduct and presentation of research and other information published in medical journals.
- Editorial policy
- Peer review policy
- Commercial policy
- Ethical rules - Links of interest, human and animal rights, informed patient consent
- Corrections, retractions and expressions of reservations
- Copyright, Open Access and data sharing
english e-sectionAll articles >
Ahead of print
Optimising the evaluation of therapeutic response to first-line treatment of diffuse large B cell lymphoma
By Fabrice Jardin
Online since 16/02/2022
Enhancers, spatial chromosome structuring and pathological changes: towards a better understanding of complex genome alterations
By Éric Soler
By Yves Beuzard